REATA PHARMACEUTICALS INC-A (RETA) Stock Analyst Earnings Estimates
NASDAQ:RETA - Nasdaq - US75615P1030 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.02M -65.99% | 11.49M 27.38% | 2.216M -80.71% | 92.691M 4,082.81% | 405.2M 337.15% | 668.5M 64.98% | 942.78M 41.03% | 1.411B 49.66% | 1.736B 23.03% | 1.942B 11.87% | 2.085B 7.36% | |
| EBITDA YoY % growth | -225.19M 20.79% | -243.505M -8.13% | -276.904M -13.72% | -312.868M -12.99% | -45.257M 85.53% | 109.47M 341.88% | 128.51M 17.39% | 395.72M 207.93% | 665.17M 68.09% | 834.08M 25.39% | 1.02B 22.29% | |
| EBIT YoY % growth | -226.33M 20.65% | -244.708M -8.12% | -278.034M -13.62% | -369.477M -32.89% | -89.684M 75.73% | 206.32M 330.05% | 531.42M 157.57% | 972.47M 82.99% | 1.218B 25.25% | 1.383B 13.55% | 1.448B 4.70% | |
| Operating Margin | -2,509.20% | -2,129.75% | -12,546.66% | -398.61% | -22.13% | 30.86% | 56.37% | 68.92% | 70.16% | 71.22% | 69.45% | |
| EPS YoY % growth | -6.98 -38.77% | -8.18 -17.19% | -8.54 -4.40% | -6.81 20.24% | -4.48 34.18% | 3.13 169.81% | 3.08 -1.59% | 8.29 169.21% | 13.40 61.62% | 16.39 22.30% | 19.56 19.35% |
All data in USD
| Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.13 1.24% | -1.88 19.52% | -2.00 36.17% | -1.31 -128.19% | -0.74 65.33% | -0.17 91.02% |
| Revenue Q2Q % growth | 29.575M 5,376.85% | 41.79M | 52.483M 26,814.36% | 92.943M 308.61% | 126.11M 326.41% | 160.73M 284.61% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -81.578M -15.74% | -82.705M -4.00% | -75.629M 31.53% | -48.528M 40.24% | -25.33M 68.95% | -2.262M 97.26% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 4.65 330.20% | -2.93 | 7.58 | 258.50% |
| Q1 2023 Q2Q % growth | -3.14 -54.68% | -2.47 | -0.67 | -27.16% |
| Q4 2022 Q2Q % growth | -2.33 0.85% | -2.25 | -0.08 | -3.37% |
| Q3 2022 Q2Q % growth | -2.16 -9.64% | -2.23 | 0.07 | 2.92% |
| Q2 2022 Q2Q % growth | -2.02 -1.00% | -2.06 | 0.04 | 2.03% |
| Q1 2022 Q2Q % growth | -2.03 -9.14% | -2.22 | 0.19 | 8.37% |
| Q4 2021 Q2Q % growth | -2.35 -23.68% | -2.35 | 0.00 | 0.17% |
| Q3 2021 Q2Q % growth | -1.97 -1.55% | -2.21 | 0.24 | 10.79% |
| Q2 2021 Q2Q % growth | -2.00 -19.76% | -2.10 | 0.10 | 4.66% |
| Q1 2021 Q2Q % growth | -1.86 -26.53% | -2.14 | 0.28 | 13.03% |
| Q4 2020 Q2Q % growth | -1.90 -19.50% | -2.20 | 0.30 | 13.60% |
| Q3 2020 Q2Q % growth | -1.94 -46.97% | -2.02 | 0.08 | 3.86% |
| Q2 2020 Q2Q % growth | -1.67 -46.49% | -2.89 | 1.22 | 42.29% |
| Q1 2020 Q2Q % growth | -1.47 -50.00% | -2.02 | 0.55 | 27.09% |
| Q4 2019 Q2Q % growth | -1.59 | -5.25 | 3.66 | 69.74% |
| Q3 2019 Q2Q % growth | -1.32 | -1.27 | -0.05 | -4.23% |
| Q2 2019 Q2Q % growth | -1.14 | -1.15 | 0.01 | 0.50% |
| Q1 2019 Q2Q % growth | -0.98 | -1.02 | 0.04 | 3.66% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 22.746M 2,885.04% | 120.87K | 22.625M | 18,718.57% |
| Q1 2023 Q2Q % growth | 195K -78.67% | 161.415K | 33.585K | 20.81% |
| Q4 2022 Q2Q % growth | -100.00% | 501.259K | -501.259K | -100.00% |
| Q3 2022 Q2Q % growth | 540K -92.69% | 658.155K | -118.155K | -17.95% |
| Q2 2022 Q2Q % growth | 762K -65.69% | 1.487M | -725K | -48.76% |
| Q1 2022 Q2Q % growth | 914K -2.77% | 1.584M | -670K | -42.30% |
| Q4 2021 Q2Q % growth | 933K -70.75% | 1.659M | -726K | -43.76% |
| Q3 2021 Q2Q % growth | 7.391M 427.93% | 2.116M | 5.275M | 249.29% |
| Q2 2021 Q2Q % growth | 2.221M -27.65% | 1.274M | 947K | 74.33% |
| Q1 2021 Q2Q % growth | 940K -30.37% | 1.212M | -272K | -22.44% |
| Q4 2020 Q2Q % growth | 3.19M 19.48% | 1.474M | 1.716M | 116.42% |
| Q3 2020 Q2Q % growth | 1.4M -83.01% | 1.301M | 99K | 7.61% |
| Q2 2020 Q2Q % growth | 3.07M -60.79% | 1.064M | 2.006M | 188.53% |
| Q1 2020 Q2Q % growth | 1.35M -82.63% | 2.083M | -733K | -35.19% |
| Q4 2019 Q2Q % growth | 2.67M | 6.616M | -3.946M | -59.64% |
| Q3 2019 Q2Q % growth | 8.24M | 7.581M | 659K | 8.69% |
| Q2 2019 Q2Q % growth | 7.83M | 6.977M | 853K | 12.23% |
| Q1 2019 Q2Q % growth | 7.77M | 7.089M | 681K | 9.61% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 13.57% | 35.98% | 25.36% |
| Revenue | 0% | 51.67% | 67.27% | 122.64% |